Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology
Clinical Trials: Endometrial Cancer
A listing of clinical trials currently looking for volunteers to enroll in Endometrial Cancer studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama at Birmingham
ChemoFx® PRO - A Post-Market Data Collection Study
Mobile : USA Mitchell Cancer Institute
ChemoFx® PRO - A Post-Market Data Collection Study
Arizona
Flagstaff :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Phoenix :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Scottsdale :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Sedona :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Tucson :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
California
Los Angeles :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Los Gatos : Bay Area Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Newport Beach : Investigational Site Number 1526
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
San Francisco : University of California San Francisco
ChemoFx® PRO - A Post-Market Data Collection Study
San Jose : San Jose Women's Medical Group
ChemoFx® PRO - A Post-Market Data Collection Study
View More »
Sherman Oaks : Women's Cancer Center Sherman Oaks
ChemoFx® PRO - A Post-Market Data Collection Study
Torrance : GOA Torrance Memorial
ChemoFx® PRO - A Post-Market Data Collection Study
Connecticut
New Haven : Smilow Cancer Hospital at Yale New Haven
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
New Haven : Yale University School of Medicine
Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
Florida
Boca Raton : South Florida Center for Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Clearwater : West Coast Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Delray Beach : Comprehensive Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Fort Lauderdale : Caruso and Gates MDs PA
ChemoFx® PRO - A Post-Market Data Collection Study
Fort Myers : Florida Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
View More »
Pembroke Pines : Gynecologic Oncology Associates
ChemoFx® PRO - A Post-Market Data Collection Study
Sarasota : Sarasota Memorial Hospital
ChemoFx® PRO - A Post-Market Data Collection Study
South Miami : South Miami Gynecologic Oncology Group
ChemoFx® PRO - A Post-Market Data Collection Study
Tampa : H. Lee Moffitt Cancer Center and Research Institute
Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids
West Palm Beach : Palm Beach Cancer Institute
ChemoFx® PRO - A Post-Market Data Collection Study
Georgia
Savannah : Memorial Health University Medical Center
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage III or Stage IVA Endometrial Cancer GOG 0258
Savannah : Memorial Health University Medical Center
ChemoFx® Observational Study in Gynecological Solid Tumors
Savannah : Memorial Health University Medical Center
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer GOG 0249
Savannah : Memorial Health University Medical Center
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy,
Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I
or Stage II Endometrial Cancer
Savannah : Memorial Health University Medical Center
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer GOG 0238
Savannah : Memorial Health University Medical Center
Temsirolimus With or Without Megestrol and Tamoxifen in Treating
Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
Savannah : Memorial Health University Medical Center
Trial NCT01015833 Phase III Randomized Study of Sorefenib Plus Doxorubicin versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) CALGB 80802
View More »
Augusta : Investigational Site Number 1239
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Riverdale : Southeastern Gynecologic Oncology, LLC
ChemoFx® PRO - A Post-Market Data Collection Study
Savannah : Memorial Health University Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Hawaii
Honolulu : The Queens' Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Honolulu :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Illinois
Elgin : Sherman Health
GOG 0086P A three arm randomized phase II study of Paclitaxel/carboplatin/ bevacizumab (NSC#704865, IND#7921), paclitaxel/carboplatin/TEMSIROLIMUS (NSC#683864, IND #61010) and ixabepilone (nsc#710428, ind# 59699/carboplatin/BEVACIZUMAB as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer
View More »
Arlington Heights :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Chicago : Rush University
ChemoFx® PRO - A Post-Market Data Collection Study
Evanston : NorthShore Medical Group
ChemoFx® PRO - A Post-Market Data Collection Study
Niles :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Indiana
Indianapolis : Indiana University
ChemoFx® PRO - A Post-Market Data Collection Study
Louisiana
Covington : Women's Cancer Center
ChemoFx® PRO - A Post-Market Data Collection Study
Shreveport : CHRISTUS Schumpert Health System
ChemoFx® PRO - A Post-Market Data Collection Study
Maryland
Baltimore : Sinai Hospital
ChemoFx® PRO - A Post-Market Data Collection Study
Baltimore : Greater Baltimore Medical Center
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
Silver Springs : Women's Health Specialists
ChemoFx® PRO - A Post-Market Data Collection Study
Massachusetts
Boston :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Boston : Investigational Site Number 1133
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Worcester : UMass Memorial Hospital
ChemoFx® PRO - A Post-Market Data Collection Study
Michigan
Detroit : Karmanos Cancer Institute
ChemoFx® PRO - A Post-Market Data Collection Study
Detroit : Henry Ford Health System
ChemoFx® PRO - A Post-Market Data Collection Study
Detroit :
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
Detroit :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Detroit : Investigational Site Number 1326
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
View More »
Grand Rapids : Gynecologic Oncology of West Michigan
ChemoFx® PRO - A Post-Market Data Collection Study
Minnesota
Burnsville :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Edina :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Maplewood :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Minneapolis :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
St. Paul :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
View More »
Woodbury :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Mississippi
Jackson : Mississippi Oncology Associates
ChemoFx® PRO - A Post-Market Data Collection Study
Missouri
St. Louis :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Nebraska
Lincoln : Novartis Investigative Site
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
New Jersey
Morristown :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Teaneck : Gara M Sommers MD
ChemoFx® PRO - A Post-Market Data Collection Study
Voorhees : Cooper Health System
ChemoFx® PRO - A Post-Market Data Collection Study
New York
Albany : Women's Cancer Care Associates
ChemoFx® PRO - A Post-Market Data Collection Study
Atlantic Beach : St. John's Episcopal Hospital
ChemoFx® PRO - A Post-Market Data Collection Study
Bronx : Montefiore Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Buffalo : Roswell Park Cancer Institute
ChemoFx® PRO - A Post-Market Data Collection Study
Manhassett : North Shore LIJ Health System
ChemoFx® PRO - A Post-Market Data Collection Study
View More »
New York :
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
New York :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
North Carolina
Asheville : Hope: A Women's Cancer Center
ChemoFx® PRO - A Post-Market Data Collection Study
Chapel Hill :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Charlotte : Blumenthal Cancer Center
ChemoFx® PRO - A Post-Market Data Collection Study
Charlotte : Presbyterian Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Cleveland :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
View More »
Durham : Duke University Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Durham :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Wilmington : North Hanover Regional Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Winston-Salem :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Ohio
Cincinnati : University of Cincinnati
ChemoFx® PRO - A Post-Market Data Collection Study
Columbus : OSU Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Columbus : Investigational Site Number 1325
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Oklahoma
Oklahoma City : Oklahoma Gynecologic Oncology Group
ChemoFx® PRO - A Post-Market Data Collection Study
Oklahoma City : Investigational Site Number 1434
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Oregon
Eugene :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Portland : Oregon Health & Science University
ChemoFx® PRO - A Post-Market Data Collection Study
Portland :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Springfield :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Tualatin :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Pennsylvania
Abington : Investigational Site Number 1132
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Philadelphia : Investigational Site Number 1134
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Pittsburgh : Pittsburgh Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Rhode Island
Providence : Investigational Site Number 1142
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
South Carolina
Charleston :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
South Dakota
Sioux Falls : Sandford USD Health System
ChemoFx® PRO - A Post-Market Data Collection Study
Tennessee
Chattanooga : Novartis Investigative Site
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Chattanooga : Chattanooga Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Chattanooga : Chattanooga's Program in Women's Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Knoxville : Thomas W. McDonald MD
ChemoFx® PRO - A Post-Market Data Collection Study
Nashville :
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
Texas
Austin :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Bedford :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Dallas : North Texas Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Fort Worth :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Ft. Sam Houston : Brooke Army Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
View More »
Houston : UT MD Anderson Cancer Center
Chemoradiation-Induced Nausea and Emesis: Quality of Life
Houston : St. Luke's Episcopal Hospital
Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)
Houston : Texas Women's Hospital
Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)
Houston : UT MD Anderson Cancer Center
Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)
San Antonio : South Texas Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
Tyler :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Virginia
Annandale : North Virigina Pelvic Surgery Associates
ChemoFx® PRO - A Post-Market Data Collection Study
Hampton :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Newport News :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Norfolk :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Roanoke : Carilion Clinic Gynecologic Oncology
ChemoFx® PRO - A Post-Market Data Collection Study
View More »
Virginia Beach :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Washington
Vancouver :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
West Virginia
Morgantown : Mohammed Ashraf MD
ChemoFx® PRO - A Post-Market Data Collection Study
Wisconsin
West Allis : Aurora West Allis Medical Center
ChemoFx® PRO - A Post-Market Data Collection Study
Belgium
Edegem : Investigational Site Number 3219
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Kortrijk : Investigational Site Number 3212
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Leuven : Local Institution
A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer
Leuven :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Leuven : Investigational Site Number 3211
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
View More »
Namur : Investigational Site Number 3213
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Wilrijk : Investigational Site Number 3218
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Yvoir :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Bulgaria
Pleven :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Plovdiv :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Sofia :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Hungary
Gyor :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Korea, Republic of
Seoul : Asan Medical Center
Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer
Poland
Lublin :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Poznan :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Warszawa :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Romania
Bucharest :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Cluj-Napoca :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Russian Federation
Barnaul :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Novgorod :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Novosibirsk :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Petersburg :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Tula :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
View More »
Vladivostok :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
Ukraine
Donetsk-92 :
Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression
